Advertisement
Canada markets close in 6 hours 1 minute

  • S&P/TSX

    22,355.12
    +95.96 (+0.43%)
     

  • S&P 500

    5,188.68
    +1.01 (+0.02%)
     

  • DOW

    39,117.78
    +61.39 (+0.16%)
     

  • CAD/USD

    0.7301
    +0.0013 (+0.17%)
     

  • CRUDE OIL

    79.18
    +0.19 (+0.24%)
     

  • Bitcoin CAD

    83,679.64
    -1,730.78 (-2.03%)
     

  • CMC Crypto 200

    1,316.48
    +16.38 (+1.26%)
     

  • GOLD FUTURES

    2,327.60
    +5.30 (+0.23%)
     

  • RUSSELL 2000

    2,053.66
    -1.48 (-0.07%)
     

  • 10-Yr Bond

    4.4940
    +0.0020 (+0.04%)
     

  • NASDAQ

    16,274.96
    -27.79 (-0.17%)
     

  • VOLATILITY

    13.26
    +0.26 (+2.00%)
     

  • FTSE

    8,379.06
    +25.01 (+0.30%)
     

  • NIKKEI 225

    38,073.98
    -128.39 (-0.34%)
     

  • CAD/EUR

    0.6779
    +0.0003 (+0.04%)
     
MARKETS LIVE BLOG:

STOCKS WOBBLE AT OPEN AS INVESTORS LOOK FOR INSPIRATION

Airbnb shares slump as gloomy Q2 forecasts fan slowdown worries

New Strong Sell Stocks for August 25th

Zacks Equity Research
·1 min read

Here are five stocks added to the Zacks Rank #5 (Strong Sell) List today:

Beam Global BEEM is a cleantech company, designs, develops, engineers, manufactures, and sells renewably energized products. The Zacks Consensus Estimate for its current year earnings has been revised 73.3% downward over the last 30 days.

Coherus BioSciences, Inc. CHRS is a biopharmaceutical company that focuses on the biosimilar and immuno-oncology market. The Zacks Consensus Estimate for its current year earnings has been revised nearly 21% downward over the last 30 days.

Kamada Ltd. KMDA develops, produces, and markets plasma-derived protein therapeutics for orphan indications. The Zacks Consensus Estimate for its current year earnings has been revised 35.3% downward over the last 30 days.

ADVERTISEMENT

Neuronetics, Inc. STIM is a commercial stage medical technology company. The Zacks Consensus Estimate for its current year earnings has been revised 24.2% downward over the last 30 days.

Phunware, Inc. PHUN provides integrated software platform. The Zacks Consensus Estimate for its current year earnings has been revised 32.1% downward over the last 30 days.

View the entire Zacks Rank #5 List.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Coherus BioSciences, Inc. (CHRS) : Free Stock Analysis Report
 
Kamada Ltd. (KMDA) : Free Stock Analysis Report
 
Neuronetics, Inc. (STIM) : Free Stock Analysis Report
 
Phunware, Inc. (PHUN) : Free Stock Analysis Report
 
Beam Global (BEEM) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research